Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives Fibrosis. Sapao P, Roberson EDO, Shi B, Assassi S, et al. J Invest Dermatol 2023;143:284-293.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sapao P, Roberson EDO, Shi B, Assassi S, et al. Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives Fibrosis. J Invest Dermatol 2023;143:284-293.
PMID: 36116512